Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers.
Article in Current Topics in Medicinal Chemistry (January 2019)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Thymoquinone‐induced antitumor and apoptosis in human lung adenocarcinoma cells
Article in Journal of Cellular Physiology (November 2018)
Krukovine Suppresses KRAS-Mutated Lung Cancer Cell Growth and Proliferation by Inhibiting the RAF-ERK Pathway and Inactivating AKT Pathway
Article in Frontiers in Pharmacology (August 2018)